Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
803 просмотров
22.06.2021
00:02:02
Описание
Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was authorised for emergency usage in the country. #Covid19 #BharatBiotech #Covaxin
Комментарии